Jury's Task In Ohio Opioid MDL Trial Divides Drug Cos.

Law360 (September 19, 2019, 11:17 PM EDT) -- Drug companies involved in multidistrict opioid litigation voiced divergent views in Ohio federal court Thursday on the jury's role in a looming bellwether trial, a question with significant implications for a potential multibillion-dollar remedy.

Johnson & Johnson filed a brief saying it does not want a jury to decide public nuisance claims in an upcoming Ohio federal trial in multidistrict opioid litigation. (AP) In separate briefs, Johnson & Johnson and drug distributors differed on whether a jury should examine allegations they created a public nuisance in the form of an opioid addiction epidemic. As currently planned, a jury will decide whether...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS